David G. Lowe
Overview
David G. Lowe received an average of $1M in total compensation, including $364K in salary, at Aeglea BioTherapeutics from 2015 to 2017.
Source: SEC filings on April 16, 2018 and April 21, 2017.
Related executives
We found nine more executives who work or worked at Aeglea BioTherapeutics.
Anthony Quinn
Aeglea BioTherapeutics
Chief Executive Officer
Jeffrey Goldberg
Aeglea BioTherapeutics
Chief Executive Officer
Leslie Sloan
Aeglea BioTherapeutics
Chief Operating Officer
Jonathan Alspaugh
Aeglea BioTherapeutics
Chief Financial Officer
Jim Kastenmayer
Aeglea BioTherapeutics
Chief Executive Officer
Michael Hanely
Aeglea BioTherapeutics
Chief Operating Officer
Charles York
Aeglea BioTherapeutics
Chief Financial Officer
James Wooldridge
Aeglea BioTherapeutics